Table 1 Clinical characteristics and laboratory values of study sample according to polycystic ovary syndrome (PCOS) and glucose tolerance status
From: The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level
| Â | PCOS | Non-PCOS | ||
|---|---|---|---|---|
| Â | NGT | IGT | NGT | IGT |
No. | 33 | 30 | 35 | 28 |
Age (y) | 26.1 ± 2.4 | 27.2 ± 3.1 | 28.4 ± 3.1 | 29.4 ± 3.8 |
BMI (kg/m 2 ) | 21.8 ± 2.7 | 24.5 ± 3.1b | 21.7 ± 3.2 | 20.6 ± 2.6 |
WHR | 0.9 ± 0.6 | 0.9 ± 0.6 | 0.9 ± 0.7 | 0.9 ± 0.9 |
FSH (mIU/mL) | 6.3 ± 1.6 | 5.5 ± 1.5a | 6.3 ± 1.6 | 7.0 ± 3.9 |
LH (mIU/mL) | 9.9 ± 3.9 | 8.6 ± 7.1 | 6.4 ± 2.0 | 4.3 ± 2.0d |
Total T (ng/dL) | 46.4 ± 11.7 | 47.5 ± 17.0 | 39.8 ± 10.0 | 36.0 ± 13.1 |
TG (mmol/L) | 1.2 ± 0.5 | 1.9 ± 0.6b | 1.3 ± 0.5 | 1.2 ± 0.6 |
TC (mmol/L) | 4.4 ± 0.6 | 4.8 ± 0.6a | 4.2 ± 0.8 | 4.2 ± 0.8 |
HDL-C (mmol/L) | 1.6 ± 0.3 | 1.2 ± 0.2b | 1.50 ± 0.3 | 1.4 ± 0.5 |
LDL-C (mmol/L) | 2.4 ± 0.5 | 2.7 ± 0.2b | 2.6 ± 0.4 | 2.3 ± 0.5c |
SBP (mmHg) | 113.8 ± 14.9 | 125.9 ± 13.6b | 123.7 ± 13.3 | 112.2 ± 15.1d |
DBP (mmHg) | 77.1 ± 9.8 | 82.9 ± 11.4a | 76.9 ± 8.0 | 78.0 ± 10.7 |
FBG (mmol/L) | 5.5 ± 0.5 | 6.5 ± 0.8b | 5.3 ± 0.4 | 5.8 ± 0.7d |
2h_OGTT (mmol/L) | 7.0 ± 0.5 | 9.2 ± 0.8b | 7.1 ± 0.5 | 9.8 ± 1.0d |
FIns (mU/L) | 12.0 ± 3.7 | 13.6 ± 4.8 | 10.3 ± 1.5 | 13.6 ± 5.3d |
HbA 1 c (%) | 5.3 ± 0.4 | 6.0 ± 0.9b | 5.5 ± 0.2 | 6.0 ± 0.7d |
HOMA-IR | 2.9 ± 0.9 | 3.9 ± 1.5b | 2.4 ± 0.4 | 3.5 ± 1.4d |
Preptin (pg/mL) | 413.7 ± 106.6 | 522.1 ± 135.1b | 406.1 ± 79.9 | 466.4 ± 121.1c |